Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.50 | €5.34 | 256.208% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.75 | €17.78 | 103.191% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €113.80 | €130.00 | 14.236% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.96 | €26.95 | 145.891% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.82 | €5.00 | 3.734% |
| Neurocrine Bioscience | 29 | 0 | 6 | 0 | €128.55 | €140.60 | 9.377% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.23 | €4.63 | 43.081% |
| United Therapeutics | 19 | 0 | 4 | 0 | €251.30 | €287.40 | 14.366% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €281.90 | €296.16 | 5.057% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.96 | €26.01 | 37.165% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.60 | €30.00 | 105.479% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.66 | €11.05 | 95.318% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.49 | - | - |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €144.78 | €175.11 | 20.950% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €95.81 | €116.71 | 21.817% |
| Corcept Therapeutics Inc. | 11 | 0 | 2 | 0 | €25.75 | €35.43 | 37.590% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.84 | €13.77 | 1548.474% |
| Eli Lilly Corp. | 49 | 0 | 6 | 0 | €744.00 | €776.16 | 4.323% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €145.70 | €184.76 | 26.809% |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.40 | €28.29 | 20.900% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |